Shanxi C&Y Pharmaceutical Co.,Ltd. Posted 5.5 Million Yuan Net Loss in First Half of 2022

Shanxi C&Y Pharmaceutical Co.,Ltd. (山西仟源医药集团股份有限公司) (300254.SZ) reported a net loss of 5.5 million yuan in the first half of 2022, reversing a net profit of 6.2 million yuan for the same period in the previous year.

Meanwhile, the company posted 405 million yuan in revenue, down 11.5% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 759.3 million yuan in total liabilities, with a liability-to-asset ratio of 47.5%.